djusted EBITDA of greater than $150 million, updated from prior guidance of Adjusted EBITDA between $146 million and $150 million
Aveanna Healthcare Revises FY24 Revenue Forecast To Greater Than $1.97B (Est $1.975B), Updated From Prior Guidance Of $1.96M-$1.98B
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.